Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. [electronic resource]
Producer: 20060213Description: 619-25 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Amputation, Surgical
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Chemotherapy, Adjuvant -- adverse effects
- Dacarbazine -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Extremities
- Female
- Humans
- Ifosfamide -- administration & dosage
- Male
- Mesna -- administration & dosage
- Middle Aged
- Neoadjuvant Therapy -- methods
- Radiotherapy, Adjuvant -- adverse effects
- Risk Assessment
- Sarcoma -- drug therapy
- Survival Analysis
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.